[1]
Yang, J., Zhao, M., Zhou, X., Yan, M., Zhao, X. and Li, F. 2025. Cost-Effectiveness of Sorafenib, Lenvatinib, and FOLFOX4 for Advanced Hepatocellular Carcinoma in China. Journal of Health Science and Medical Research. 43, 4 (Jun. 2025), e20251153. DOI:https://doi.org/10.31584/jhsmr.20251153.